Monuvir 200Mg - Anti-COVID Generic Drug Molnupiravir
|Packaging Size||10 Capsule|
|Shelf life||2 Years|
|Country of Origin||Made in Bangladesh|
Molnupiravir is the world’s first oral pill to treat symptomatic COVID-19 which was approved by the UK’s Medicines and Healthcare products Regulatory Agency on 4 November 2021. Molnupiravir is originally developed by the US based pharma major Merck, Sharp & Dohme (MSD) and Ridgeback Biotherapeutics.